A Study of TQ-B3525 Tablet in the Treatment of Relapsed / Refractory Mantle Cell Lymphoma (MCL)

PHASE2UnknownINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

July 20, 2020

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
Relapsed / Refractory Mantle Cell Lymphoma (MCL)
Interventions
DRUG

TQ-B3525

TQ-B3525 tablet administered 20mg orally, once daily in 28-day cycle.

Trial Locations (39)

210009

RECRUITING

Jiangsu Cancer Hospital, Nanjing

Unknown

NOT_YET_RECRUITING

Anhui Cancer Hospital, Hefei

NOT_YET_RECRUITING

The First Affiliated Hospital of Anhui Medical University, Hefei

RECRUITING

Beijing Boren Hospital, Beijing

NOT_YET_RECRUITING

Beijing Shijitan Hospital Affiliated to Capital Medical University, Beijing

NOT_YET_RECRUITING

Cancer Hospital of Chinese Academy of Medical Sciences, Beijing

NOT_YET_RECRUITING

The Fifth Medical Center of PLA General Hospital, Beijing

NOT_YET_RECRUITING

The Third Hospital of Peking University, Beijing

NOT_YET_RECRUITING

Fujian Cancer Hospital, Fuzhou

NOT_YET_RECRUITING

Union Hospital Affiliated to Fujian Medical University, Fuzhou

NOT_YET_RECRUITING

The First Affiliated Hospital of Xiamen University, Xiamen

NOT_YET_RECRUITING

The Second Hospital of Lanzhou University, Lanzhou

NOT_YET_RECRUITING

Guangdong Provincial People's Hospital, Guangzhou

NOT_YET_RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

NOT_YET_RECRUITING

Guangxi Medical University Affiliated Tumor Hospital, Nanning

RECRUITING

Fourth Hospital of Hebei Medical University, Shijiazhuang

NOT_YET_RECRUITING

Henan Cancer Hospital, Zhengzhou

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

NOT_YET_RECRUITING

Hunan Cancer Hospital, Changsha

NOT_YET_RECRUITING

Huai'an first people's Hospital, Huaian

NOT_YET_RECRUITING

Nanjing Drum Tower Hospital, Nanjing

NOT_YET_RECRUITING

Nantong Tumor Hospital, Nantong

NOT_YET_RECRUITING

The First Affiliated Hospital of Suzhou University, Suzhou

NOT_YET_RECRUITING

Jiangxi Cancer Hospital, Nanchang

NOT_YET_RECRUITING

The First Hospital of Jilin University, Changchun

NOT_YET_RECRUITING

Affiliated Zhongshan Hospital of Dalian University, Dalian

NOT_YET_RECRUITING

The First Affiliated Hospital of Dalian Medical University, Dalian

NOT_YET_RECRUITING

The Second Affiliated Hospital of Dalian Medical University, Dalian

RECRUITING

Affiliated Hospital of Binzhou Medical College, Binzhou

NOT_YET_RECRUITING

Qingdao Central Hospital, Qingdao

RECRUITING

Weifang People's Hospital, Weifang

NOT_YET_RECRUITING

Weihai Central Hospital, Weihai

NOT_YET_RECRUITING

Weihai Municipal Hospital, Weihai

NOT_YET_RECRUITING

Shanghai Tongji Hospital, Shanghai

NOT_YET_RECRUITING

Shanxi Provincial People's Hospital, Xi’an

NOT_YET_RECRUITING

Hematology Hospital of Chinese Academy of Medical Sciences, Tianjin

NOT_YET_RECRUITING

Tianjin Cancer Hospital, Tianjin

NOT_YET_RECRUITING

Tianjin Medical University General Hospital, Tianjin

NOT_YET_RECRUITING

Tianjing People's Hospital, Tianjin

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY